Researchers find potential new antibody treatment for autoimmune diseases

Jan 23, 2009

Scientists at UCSF have discovered an abnormality in a patient's immune system that may lead to safer therapies for autoimmune diseases such as rheumatoid arthritis and colitis, as well as potential new ways to treat transplant rejection.

The research identified antibodies from a woman's immune system that prevent infection-fighting T cells from moving through her blood stream and entering her body's organs to attack invaders such as bacteria or viruses. Findings appear in the current online edition of the FASEB Journal, the official journal of the Federation of American Societies for Experimental Biology.

Based on studies in which the woman's antibodies were transferred into mice, researchers hope these antibodies can be used to treat patients with autoimmunity or transplant recipients whose immune systems attack a transplanted organ or tissue.

Autoimmunity occurs when the body perceives its own cells or tissue as foreign organisms and creates an immune response to itself. Autoimmune diseases affect approximately five to eight percent of Americans and their prevalence is increasing, according to the National Institute of Allergy and Infectious Diseases. The majority of people with autoimmune diseases are women.

"This is the first selective antibody of its type discovered in a patient," said lead study author Edward J. Goetzl, MD, UCSF professor of medicine and immunology. "Antibodies that react more generally against blood cells, such as T cells, previously have been identified. However, this is the first to block a specific aspect of T-cell function. Our study offers a potential new approach to developing safer, more targeted therapies based on human antibodies."

Therapies using proper doses of these newly discovered antibodies may carry less risk of infections or tumors than current treatments, since the antibodies target T cells' specific patrolling activities, rather than their overall function.

Goetzl's team evaluated a woman with a low number of blood T cells and frequent infections in the ears, urinary tract and lungs. The infection of several organs suggested a defect in the patient's immune system similar to Acquired Immune Deficiency Syndrome (AIDS), but the patient tested negative for human immunodeficiency virus (HIV).

Further studies revealed that the patient's CD4 T cells did not move out of her lymph nodes as they would in a normal immune system because her body created antibodies to one type of sphingosine 1-phosphate (S1P) receptor. S1P is critical to appropriate immune responses since it regulates T- and B-cell movement throughout the body by interacting with its receptor. The patient's antibodies blocked the signaling that triggers T-cell movement from the thymus and lymph nodes into blood and then into many organs.

Researchers then explored whether the woman's antibodies effectively could inhibit an autoimmune response in mice. Antibodies against the S1P receptor, created from the patient's antibody-producing cells, were injected into mice that were induced to develop colitis. The result was a significant reduction in severity of their diseases, including colitis-associated weight loss, in those mice compared to mice that did not receive the antibodies.

"These results have broad biological implications, since the cells that carry out our immune responses are present in every organ," said Goetzl, director of UCSF Allergy and Immunology Research, which focuses on developing new diagnostic approaches and treatments for allergic and immunological diseases.

Source: University of California - San Francisco

Explore further: Reducing kidney injury using a quality improvement method

add to favorites email to friend print save as pdf

Related Stories

Why let your sales force influence product prices?

20 minutes ago

From the outside, you might not notice the ongoing tension within many large businesses: the battle between salespeople, on the one hand, and marketers and product managers, on the other. Because the salespeople ...

Breakthrough elastic cloud-to cloud networking

51 minutes ago

Scientists from AT&T, IBM and Applied Communication Sciences (ACS) announced a proof-of-concept technology that reduces set up times for cloud-to-cloud connectivity from days to seconds. This advance is a major step forward ...

Groundwater is safe in potential N.Y. fracking area

10 minutes ago

Two Cornell hydrologists have completed a thorough groundwater examination of drinking water in a potential hydraulic fracturing area in New York's Southern Tier. They determined that drinking water in potable ...

Recommended for you

Fatigue, fear are daily lot of Ebola fighters: experts

3 hours ago

Doctors, nurses and hospital workers fighting the Ebola epidemic in west Africa are struggling with a daily burden of exhaustion, shortage of staff and fear for themselves over the deadly virus, specialists say.

Hong Kong makes Ebola 'contingency' measures

6 hours ago

Hong Kong said Wednesday it was quarantining all people from Guinea, Sierra Leone and Liberia who were showing Ebola-like symptoms on arrival in the city, as fears grow worldwide about the spread of the deadly virus.

User comments : 0